CLASStime: Helicobacter pylori

1. Chen YC, Malfertheiner P, Yu HT, et al. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology 2024;166(4):605–19.

2. Schauer C. How to treat: Helicobacter pylori. New Zealand Doctor, 10 April 2024.

3. Katelaris P, Hunt R, Bazzoli F, et al. World Gastroenterology Organisation Global Guidelines: Helicobacter pylori. World Gastroenterology Organisation, May 2021.

4. Hsiang J, Selvaratnam S, Taylor S, et al. Increasing primary antibiotic resistance and ethnic differences in eradication rates of Helicobacter pylori infection in New Zealand–a new look at an old enemy. N Z Med J 2013;126(1384):64–76.

5. de Brito BB, da Silva FAF, Soares AS, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol 2019;25(37):5578–89.

6. Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 2022;53(1):33–50.

7. Teng AM, Blakely T, Baker MG, Sarfati D. The contribution of Helicobacter pylori to excess gastric cancer in Indigenous and Pacific men: a birth cohort estimate. Gastric Cancer 2017;20(4):752–55.

8. BPACnz. H. pylori: who to test and how to treat. Updated: 26 September 2024.

9. Patel SK, Pratap CB, Jain AK, et al. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol 2014;20(36):12847–59.

10. Chey WD, Howden CW, Moss SF, et al. ACG clinical guideline: Treatment of Helicobacter pylori infection. Am J Gastroenterol 2024;119(9):1730–53.

11. New Zealand Formulary. NZF v152; 1 February 20245.

12. National Institute for Health Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Updated: 18 October 2019.

13. Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: current status and future concepts. World J Gastroenterol 2014;20(18):5283–93.